Our Medicines
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. We are investing billions in Research and Development (R&D), which includes the discovery and development of new medicines.
Below is a list of our company's marketed products available in Canada. Any linked documents and websites are intended only for residents of Canada 18 years or older.
If you are not a resident of Canada, please refer to the full prescribing information approved by the relevant governmental authority of the country where you are located and consult your physician for professional medical advice and services.
For Medical Information, or to Report Side Effects/Adverse Reactions or to Report Product Quality Complaints – please contact Medical Information
(toll free)
ABRAXANE® for Injectable Suspension (paclitaxel powder for injectable suspension nanoparticle, albumin-bound (nab®) paclitaxel)
BARACLUDE® (entecavir)
BREYANZI® (lisocabtagene maraleucel)
CAMZYOSTM (mavacamten capsules)
CeeNU® (lomustine)
ELIQUIS® (apixaban)
IDHIFA® (enasidenib)
INREBIC® (fedratinib capsules)
ISTODAX® lyophilized powder for injection (romidepsin for injection)
KENALOG-10® Injection (triamcinolone)
KENALOG-40® Injection (triamcinolone)
ONUREG® (azacitidine tablets)
OPDIVO® (nivolumab)
OPDUALAGTM (nivolumab and relatlimab for injection)
ORENCIA® (abatacept)
POMALYST® (pomalidomide)
REBLOZYL® (luspatercept for injection)
REVLIMID® (lenalidomide capsules)
REYATAZ® (atazanavir)
SOTYKTUTM (deucravacitinib)
SPRYCEL® (dasatinib)
THALOMID® (thalidomide capsules House Standard)
VIDAZA® (azacitidine for injection)
YERVOY® (ipilimumab)
ZEPOSIA® (ozanimod)